{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:26:37Z","timestamp":1790047597457,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372138"],"award-info":[{"award-number":["81372138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30873094"],"award-info":[{"award-number":["30873094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572384"],"award-info":[{"award-number":["81572384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81090421"],"award-info":[{"award-number":["81090421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"863 National High Technology Research and Development Program of China","award":["2012AA020206"],"award-info":[{"award-number":["2012AA020206"]}]},{"name":"SKLDR\/SIMM","award":["SIMM1403ZZ-01"],"award-info":[{"award-number":["SIMM1403ZZ-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bcp.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T14:51:19Z","timestamp":1452783079000},"page":"118-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein"],"prefix":"10.1016","volume":"103","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.01.003_b0005","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.01.003_b0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.01.003_b0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.drudis.2015.01.008","article-title":"Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA","volume":"20","author":"Ahmed","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2016.01.003_b0020","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/gutjnl-2014-307023","article-title":"Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians","volume":"64","author":"Arends","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2016.01.003_b0025","first-page":"1","article-title":"Surveillance for acute viral hepatitis \u2013 United States, 2006","volume":"57","author":"Wasley","year":"2008","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.bcp.2016.01.003_b0030","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1365-2036.2011.04869.x","article-title":"Review article: current antiviral therapy of chronic hepatitis B","volume":"34","author":"Ayoub","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.01.003_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1570-9639(04)00054-8","article-title":"Structure, function, and mechanism of ribonucleotide reductases","volume":"1699","author":"Kolberg","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2016.01.003_b0040","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/14728222.2013.840293","article-title":"Targeting ribonucleotide reductase for cancer therapy","volume":"17","author":"Shao","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2016.01.003_b0045","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2016.01.003_b0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.virol.2010.07.042","article-title":"Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes","volume":"407","author":"Gearhart","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2016.01.003_b0055","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.23519","article-title":"Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene","volume":"51","author":"Cohen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.01.003_b0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2015.05.017","article-title":"Hepatitis B virus induces RNR-R2 expression via DNA damage response activation","volume":"63","author":"Ricardo-Lax","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2016.01.003_b0065","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.humpath.2010.06.001","article-title":"Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro","volume":"41","author":"Morikawa","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcp.2016.01.003_b0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000320553","article-title":"RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis\/cirrhotic liver tissues and human hepatocellular carcinoma (HCC)","volume":"26","author":"Wang","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2016.01.003_b0075","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep.26929","article-title":"Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog\/Akt1 pathway in hepatocellular carcinoma","volume":"59","author":"Tian","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.01.003_b0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/thoraxjnl-2014-205914","article-title":"A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer","volume":"70","author":"Pilkington","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.bcp.2016.01.003_b0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V82.2.398.398","article-title":"Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group","volume":"82","author":"Hehlmann","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.01.003_b0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.01.003_b0095","first-page":"s34","article-title":"The place of hydroxyurea in the treatment of primary brain tumors","volume":"19","author":"Levin","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bcp.2016.01.003_b0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0026-895X(25)09811-6","article-title":"Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2\u2032,3\u2032-dideoxynucleosides","volume":"46","author":"Gao","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.01.003_b0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.7973634","article-title":"Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication","volume":"266","author":"Lori","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.01.003_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2007.08.009","article-title":"Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and\/or the DNA polymerase genes","volume":"77","author":"Sergerie","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2016.01.003_b0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00705-010-0624-1","article-title":"Hydroxyurea as an inhibitor of hepatitis C virus RNA replication","volume":"155","author":"Nozaki","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bcp.2016.01.003_b0120","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.bmcl.2012.08.108","article-title":"Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine","volume":"22","author":"Clouser","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2016.01.003_b0125","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bcp.2009.06.103","article-title":"Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase","volume":"78","author":"Zhu","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.01.003_b0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bcp.2004.11.016","article-title":"Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay","volume":"69","author":"Shao","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.01.003_b0135","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0006-2952(98)00042-2","article-title":"Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells","volume":"55","author":"Zhou","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.01.003_b0140","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1074\/jbc.M113.524546","article-title":"The conserved Lys-95 charged residue cluster is critical for the homodimerization and enzyme activity of human ribonucleotide reductase small subunit M2","volume":"289","author":"Chen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.01.003_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.05.007","article-title":"Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity","volume":"108","author":"Cai","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2016.01.003_b0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.24551","article-title":"Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma","volume":"54","author":"Wong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.01.003_b0155","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.26514","article-title":"Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells","volume":"58","author":"Song","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.01.003_b0160","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1073\/pnas.0607837103","article-title":"PGC-1alpha controls hepatitis B virus through nutritional signals","volume":"103","author":"Shlomai","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.01.003_b0165","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.3748\/wjg.v18.i27.3617","article-title":"Effect of interferon-gamma and tumor necrosis factor-alpha on hepatitis B virus following lamivudine treatment","volume":"18","author":"Shi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2016.01.003_b0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.bcp.2016.01.003_b0175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2016.01.003_b0180","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/135965350501000507","article-title":"Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV","volume":"10","author":"Yang","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bcp.2016.01.003_b0185","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro","volume":"77","author":"Delaney","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.01.003_b0190","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1073\/pnas.1502400112","article-title":"Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis","volume":"112","author":"Ebert","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.01.003_b0195","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1073\/pnas.1502390112","article-title":"Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus","volume":"112","author":"Ebert","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.01.003_b0200","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.01.003_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tibs.2008.09.008","article-title":"Tinkering with a viral ribonucleotide reductase","volume":"34","author":"Lembo","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2016.01.003_b0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0304-4165(89)90095-0","article-title":"Deoxyribonucleoside triphosphate pools in regenerating rat liver: effect of hydroxyurea and exogenous deoxypyrimidines","volume":"992","author":"R\u00f6ttgen","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2016.01.003_b0215","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1592\/phco.26.12.1745","article-title":"Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection","volume":"26","author":"Sims","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bcp.2016.01.003_b0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2016.01.003_b0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.coviro.2012.05.008","article-title":"Diverse roles of hepatitis B virus in liver cancer","volume":"2","author":"Fallot","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bcp.2016.01.003_b0230","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/hep.22962","article-title":"Hepatitis B and hepatocellular carcinoma","volume":"49","author":"Di Bisceglie","year":"2009","journal-title":"Hepatology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:00:11Z","timestamp":1748750411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":46,"alternative-id":["S0006295216000204"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.01.003","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}